We analyzed the effects of MK2206 through a procedure similar to the one we used for GDC0941, performing a comparison of phosphoproteomic profiles after incubation of primary human AML cells in insulin with and without MK2206 (Fig. 4 middle, Fig. 5). This evidence concerns the gene INS and acute myeloid leukemia.